Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo.
about
Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in CancerHypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under HypoxiaNuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells.The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells.Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells.Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review.Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63.Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC).Naturally occurring benzoic acid derivatives retard cancer cell growth by inhibiting histone deacetylases (HDAC).Overexpression and RNA interference of TwDXR regulate the accumulation of terpenoid active ingredients in Tripterygium wilfordii.Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles.Combination Therapies Targeting HDAC and IKK in Solid Tumors.Synthesis and characterisation of celastrol derivatives as potential anticancer agents.Celastrol and Its Role in Controlling Chronic Diseases.A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F.ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
P2860
Q28073020-32F33165-0B65-4117-BA91-ACDDB2EAEDA7Q28551450-1847D807-A8DE-4113-B61E-3088F3220813Q36916380-4220C060-50DE-4528-A56A-DBF4BE33C2E8Q37636533-9E565032-E3CA-4C8E-9693-BB3C31C0924DQ38705383-6305174B-8F35-4ADE-9D18-8CCEE47BB90AQ38876792-0AF6A069-A03D-49F7-886A-C62EE9987027Q39305660-F106BE6B-242A-4E24-B1DC-B6905ECCA7F3Q40975866-7FC82433-5978-4D33-AC09-F59DFD723F64Q46251027-0669DF39-0CCF-4F33-AE84-4DCCE054779AQ48142968-88CACA8A-F7B9-46B4-8797-C021A9FB62FCQ48360910-499FDC87-9283-4126-AB06-8740BF5AD056Q49887095-5683090C-7220-4B30-B05C-8B6702379B55Q49887757-CAFBAF7E-4A33-4F6B-8EA2-A5EE382B08C4Q49909142-B466D80C-7912-458A-9EE4-764E17DEF92EQ51458495-A14EF5DE-8E88-4C51-8D4F-F75F0B139125Q55407628-A385980D-5E75-4A64-AF5A-66E0A1D96440Q58792092-50A3E1C9-7D08-4D17-BA9A-7747A8657589
P2860
Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Simultaneous NF-κB inhibition ...... and SAHA in vitro and in vivo.
@en
Simultaneous NF-κB inhibition ...... and SAHA in vitro and in vivo.
@nl
type
label
Simultaneous NF-κB inhibition ...... and SAHA in vitro and in vivo.
@en
Simultaneous NF-κB inhibition ...... and SAHA in vitro and in vivo.
@nl
prefLabel
Simultaneous NF-κB inhibition ...... and SAHA in vitro and in vivo.
@en
Simultaneous NF-κB inhibition ...... and SAHA in vitro and in vivo.
@nl
P2093
P2860
P356
P1476
Simultaneous NF-κB inhibition ...... and SAHA in vitro and in vivo
@en
P2093
Jianshu Lou
Linhan Zhuang
Qiaojun He
Renhua Gai
Yingying Fu
P2860
P304
P356
10.1002/IJC.28810
P50
P577
2014-03-07T00:00:00Z